How has been the historical performance of GPT Healthcare?
GPT Healthcare experienced significant financial growth from March 2021 to March 2022, with net sales increasing to 337.42 Cr and profit after tax rising to 41.66 Cr. The company improved its operating profit margin and reduced total debt, reflecting strong overall performance.
Answer:The historical performance of GPT Healthcare shows significant growth in various financial metrics from March 2021 to March 2022.Breakdown:
In the fiscal year ending March 2022, GPT Healthcare reported net sales of 337.42 Cr, an increase from 242.75 Cr in the previous year. The total operating income also rose to 337.42 Cr from 242.75 Cr. Total expenditure, excluding depreciation, increased to 263.58 Cr from 193.76 Cr, primarily driven by higher raw material costs and employee expenses. Operating profit (PBDIT) grew to 78.83 Cr from 55.10 Cr, reflecting an improved operating profit margin of 21.88%, up from 20.18%. Profit before tax surged to 54.08 Cr from 28.88 Cr, leading to a profit after tax of 41.66 Cr, compared to 21.09 Cr in the prior year. The earnings per share (EPS) increased to 5.22 from 3.92. On the balance sheet, total assets grew to 319.51 Cr from 310.61 Cr, while total liabilities also increased to 319.51 Cr from 310.61 Cr. The company reduced its total debt to 95.52 Cr from 122.93 Cr. Cash flow from operating activities improved to 65.00 Cr from 42.00 Cr, contributing to a closing cash and cash equivalent of 8.00 Cr, up from 4.00 Cr. Overall, GPT Healthcare demonstrated strong financial growth and improved profitability in the reported period.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
